News

Cell-VIB Symposium: Angiogenesis, Metabolic Regulation and Cancer Biology (July 6-8 2012, Leuven Belgium)
6 July 2012
VIB has teamed up with Cell for a symposium about angiogenesis, metabolic regulation and cancer biology, on July 6-8 2012 in Leuven, Belgium. Registration is now open.
Biomarker predicts response to cancer treatment
21 May 2012
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that can predict which patients will benefit from treatment with bevacizumab (Avastin).
Christine Van Broeckhoven given prestigious MetLife award for medical research worth $ 250,000
15 May 2012
On Tuesday, May 15, in New York, the MetLife Foundation handed its annual Award for Medical Research to Christine Van Broeckhoven, of VIB and Universiteit Antwerpen, for her pioneering research on Alzheimer's disease and related disorders.
British-American scientist gets dystonia research going at KU Leuven
11 May 2012
Dystonia is the third most common movement disorder after Parkinson's and essential tremor. In spite of this, almost no dystonia research is taking place in Belgium, whether clinical or basic. Rose Goodchild wants to change that.
Vitamin K2: new hope for Parkinson's patients
10 May 2012
Patrik Verstreken, associated with VIB and KU Leuven, succeeded in undoing the effect of one of the genetic defects that leads to Parkinson's using vitamin K2.
Ph.D. students organize 3rd International VIB Ph.D. Student Symposium VIBes in Biosciences 2012
4 May 2012
“The VIBes 2012 Organizing Committee has the pleasure to invite all Ph.D. Students to the 3rd edition of the VIB Ph.D. symposium “VIBes in Biosciences 2012”, which will take place from 5 to 7 September 2012 in the city of Ghent (Belgium).
VIB renews general management
17 April 2012
Since the start of VIB in July 1995, VIB has been led by the tandem Jo Bury and Rudy Dekeyser. From June 1st onwards Johan Cardoen will succeed Rudy Dekeyser as managing director and director tech transfer of VIB.
That is why plants grow towards the light!
16 April 2012
Have you ever wondered why stems grow upwards and roots downwards? Why plants always seem to turn towards the light and climbing plants run up the trellis rather than down?
Nanobodies can help prevent heart attacks
5 April 2012
Flemish scientists have succeeded, for the first time, in developing a technology that can distinguish between different types of arterial stenosis. Their discovery is an important step in the prevention of heart attacks and sudden death.
Stomata development in plants unraveled – a valuable discovery for environmental research
3 April 2012
Gent researchers have unraveled the action mechanism of the main plant hormone that regulates the development of stomata. This breakthrough has important implications for environmental research and for protection of plants against disease and stress.
New services at the VIB Proteomics Expertise Center (PEC)
15 February 2012
VIB Proteomics Expertise Center (PEC) enlarges its range of proteome analysis applications
Increased crop yield through better insight in molecular networks
7 February 2012
VIB and BASF Plant Science jointly develop TopYield Technology. This is the largest collaboration VIB has entered in the field of plant biotechnology, this project is supported by Flemish government agency IWT.
VIB Nucleomics Core, former VIB MAF, now offers next-gen sequencing, microarrays, nCounter analysis
26 January 2012
The VIB MicroArray Facility (MAF) is now called the VIB Nucleomics Core. Its services have extended into nucleic acid analysis, including next-gen sequencing platforms.
Both Nature and Science select VIB-VUB research as 2011 highlights
4 January 2012
Great news to start 2012. Top journals Nature and Science are featuring research from VIB researchers at Vrije Universiteit Brussel in their 2011 highlights.
Targeted blocking of necroptosis prevents fatal condition septic shock
27 December 2011
By blocking necroptosis, Peter Vandenabeele and his colleagues from from VIB-UGent were able to protect mice against the lethal condition sepsis, showing the central role of the molecule RIPK in this condition.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next»

Get news updates:

Email updates
RSS